Focus: Vivid Microscopy is an early-stage biotechnology company focused on imaging technology, headquartered in Wisconsin. Founded in 2022 and recently transitioned to public status, the company is in a foundational scaling phase.
Profile data last refreshed 8h ago · AI intelligence enriched 1w ago
Vivid Microscopy is a high-risk, high-optionality bet suitable only for career-stage professionals comfortable with opacity and early-stage execution uncertainty.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Vivid Microscopy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Vivid Microscopy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles